Bladder cancer differential diagnosis: Difference between revisions
Line 8: | Line 8: | ||
The most common presentation of bladder cancer is hematuria, in the advanced cases, the presentation can be bladder mass. | The most common presentation of bladder cancer is hematuria, in the advanced cases, the presentation can be bladder mass. | ||
Bladder cancer must be differentiated from other causes of hematuria as in the below table: | Bladder cancer must be differentiated from other causes of hematuria as in the below table: | ||
{| | {| | ||
Line 37: | Line 36: | ||
|- | |- | ||
| rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Glomerular disease|Glomerular diseases]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IgA nephropathy|IgA nephropathy (Berger nephropathy)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IgA nephropathy|IgA nephropathy]]<ref name="pmid12213946">{{cite journal| author=Donadio JV, Grande JP| title=IgA nephropathy. | journal=N Engl J Med | year= 2002 | volume= 347 | issue= 10 | pages= 738-48 | pmid=12213946 | doi=10.1056/NEJMra020109 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12213946 }}</ref><ref name="pmid21949093">{{cite journal| author=Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB et al.| title=The pathophysiology of IgA nephropathy. | journal=J Am Soc Nephrol | year= 2011 | volume= 22 | issue= 10 | pages= 1795-803 | pmid=21949093 | doi=10.1681/ASN.2011050464 | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21949093 }}</ref> [[IgA nephropathy|(Berger nephropathy)]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 53: | Line 52: | ||
* | * | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis]]<ref name="pmid11137428">{{cite journal| author=McCarthy PA, Maino DM| title=Alport syndrome: a review. | journal=Clin Eye Vis Care | year= 2000 | volume= 12 | issue= 3-4 | pages= 139-150 | pmid=11137428 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11137428 }}</ref><ref name="pmid8154501">{{cite journal| author=Bodziak KA, Hammond WS, Molitoris BA| title=Inherited diseases of the glomerular basement membrane. | journal=Am J Kidney Dis | year= 1994 | volume= 23 | issue= 4 | pages= 605-18 | pmid=8154501 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8154501 }}</ref> [[Alport syndrome|(Alport syndrome)]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 74: | Line 73: | ||
| style="background: #F5F5F5; padding: 5px;" |Genetic analysis | | style="background: #F5F5F5; padding: 5px;" |Genetic analysis | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[ | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Post-streptococcal glomerulonephritis]]<ref name="pmid15213266">{{cite journal |vauthors=Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, Boyle MD |title=Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response |journal=J. Am. Soc. Nephrol. |volume=15 |issue=7 |pages=1785–93 |date=July 2004 |pmid=15213266 |doi= |url=}}</ref><ref name="pmid20708459">{{cite journal |vauthors=Oda T, Yoshizawa N, Yamakami K, Tamura K, Kuroki A, Sugisaki T, Sawanobori E, Higashida K, Ohtomo Y, Hotta O, Kumagai H, Miura S |title=Localization of nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis |journal=Hum. Pathol. |volume=41 |issue=9 |pages=1276–85 |date=September 2010 |pmid=20708459 |doi=10.1016/j.humpath.2010.02.006 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 98: | Line 97: | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]]<ref name="pmid18039119">{{cite journal| author=Kwoh C, Shannon MB, Miner JH, Shaw A| title=Pathogenesis of nonimmune glomerulopathies. | journal=Annu Rev Pathol | year= 2006 | volume= 1 | issue= | pages= 349-74 | pmid=18039119 | doi=10.1146/annurev.pathol.1.110304.100119 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18039119 }}</ref><ref name="pmid17216262">{{cite journal |vauthors=Reidy K, Kaskel FJ |title=Pathophysiology of focal segmental glomerulosclerosis |journal=Pediatr. Nephrol. |volume=22 |issue=3 |pages=350–4 |date=March 2007 |pmid=17216262 |pmc=1794138 |doi=10.1007/s00467-006-0357-2 |url=}}</ref>'''<ref name="pmid14750104">{{cite journal| author=D'Agati VD, Fogo AB, Bruijn JA, Jennette JC| title=Pathologic classification of focal segmental glomerulosclerosis: a working proposal. | journal=Am J Kidney Dis | year= 2004| volume= 43 | issue= 2 | pages= 368-82 | pmid=14750104 | doi= | pmc= |url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14750104 }}</ref>''' | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
Line 123: | Line 122: | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]]<ref name="pmid9507491">{{cite journal| author=Couser WG| title=Pathogenesis of glomerular damage in glomerulonephritis. | journal=Nephrol Dial Transplant | year= 1998 | volume= 13 Suppl 1 | issue= | pages= 10-5 | pmid=9507491 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9507491 }}</ref><ref name="pmid8959617">{{cite journal| author=Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY| title=Modulators of crescentic glomerulonephritis. | journal=J Am Soc Nephrol | year= 1996 | volume= 7 | issue= 11 | pages= 2271-8 | pmid=8959617 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8959617 }}</ref><ref name="pmid12631105">{{cite journal |vauthors=Jennette JC |title=Rapidly progressive crescentic glomerulonephritis |journal=Kidney Int. |volume=63 |issue=3 |pages=1164–77 |date=March 2003 |pmid=12631105 |doi=10.1046/j.1523-1755.2003.00843.x |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 526: | Line 525: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |Flank, groin pain | | style="background: #F5F5F5; padding: 5px;" |Flank, groin pain | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 644: | Line 643: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Urogenital|Urogenital trauma]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Inserted [[bladder]] or [[Ureteral disease|ureteral catheters]] | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* History of truma | * History of truma | ||
Line 658: | Line 657: | ||
| style="background: #F5F5F5; padding: 5px;" |Retrograde Urethrography | | style="background: #F5F5F5; padding: 5px;" |Retrograde Urethrography | ||
|} | |} | ||
Lower abdominal mass can be classified to the gynecological and non-gynecological causes. | Lower abdominal mass can be classified to the gynecological and non-gynecological causes. |
Revision as of 19:20, 4 February 2019
Bladder cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Bladder cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Bladder cancer differential diagnosis |
Risk calculators and risk factors for Bladder cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Bladder cancer must be differentiated from renal cancer, renal stones, prostate cancer, and cystitis.
Differential Diagnosis
The most common presentation of bladder cancer is hematuria, in the advanced cases, the presentation can be bladder mass. Bladder cancer must be differentiated from other causes of hematuria as in the below table:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examina | ||||||||||||
Lab Findings | Diagnosi | ||||||||||||
Low back pain | Fever | Nausea/
Vomiting |
Urinary symptoms | Hypertension | Pitting edema | Other | |||||||
Dysuria | Frequency | Oliguria | |||||||||||
Glomerular diseases | IgA nephropathy[1][2] (Berger nephropathy) | + | - | - | - | + | + | + | - | - | Biopsy:
IgA deposited in a diffuse granular patte-rn in the mesangium |
Biopsy
| |
Hereditary nephritis[3][4] (Alport syndrome) | - | - | - | - | - | - | + | - |
|
Biopsy:
|
Genetic analysis | ||
Post-streptococcal glomerulonephritis[5][6] | +/- | + | - | - | + | + | + | + |
|
|
Biopsy
|
Biopsy | |
Focal segmental glomerular sclerosis[7][8][9] | - | - | - | - | - | - | + | + |
|
|
Biopsy
|
Biopsy | |
Rapidly progressive glomerulonephritis[10][11][12] | + | + | + | - | - | - | + | - |
|
|
Biopsy:
|
Biopsy | |
Lupus nephritis | - | + | - | - | - | - | + | + |
|
|
Biopsy,
|
Biopsy | |
Fabry disease | - | - | - | - | - | - | + | + | - |
|
Biopsy | Biopsy | |
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Tubulointerstitial diseases | + | + | + | – | – | – | – | – | Rash | Biopsy:
|
Renal biopsy | ||
Nephrolithiasis | + | ± | + | ± | ± | ± | – | – |
|
|
Abdominal CT scan without contrast | ||
Reflux nephropathy (hydronephrosis) | + | + | - | - | - | - | - | + |
|
– | |||
Malignancy | Renal cell carcinoma (RCC) | - | - | - | - | - | - | ± | ± |
|
|
|
– |
Nephroblastoma (Wilms tumor) | - | - | - | - | - | - | - | - |
|
Biopsy:
|
Biopsy | ||
Bladder cancer | - | - | - | - | ± | ± | - | - | Suprapubic pain | Ultrasound, CT scan, Biopsy | Biopsy | ||
Prostate cancer | ± | - | - | - | ± | ± | - | - | - | Ultrasound, CT scan, Biopsy | Biopsy | ||
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Familial diseases | Polycystic kidney disease | + | - | - | - | - | - | + | + |
|
Ultrasound:
CT:
Genetic testing demonstrates: Biopsy:
|
Ultrasound | |
Vascular diseases | Renal vein thrombosis | + | + | + | - | - | - | - | - |
|
|
|
Renal venography: Gold standard |
Wegner's granulomatosis polyangiitis | - | - | - | - | - | +/- | + | + |
|
|
CT chest:
Biopsy:
|
Biopsy | |
Henoch-Schönlein purpura | - | - | - | - | - | +/- | +/- | + |
|
|
Biopsy:
IgA deposited in a diffuse granular pattern in the mesangium |
Renal biopsy, and clinical syndrome | |
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Lower urinary tract diseases | Benign prostatic hyperplasia | +/- | - | - | + | + | - | - | - |
|
|
|
Biopsy |
Urolithiasis | + | +/- | + | + | + | + | - | - | Flank, groin pain |
|
Abdominppelvic CT scan without contrast | Abdominppelvic CT scan without contrast | |
Disease | Low back pain | Fever | Nausea/
Vomiting |
Dysuria | Frequency | Oliguria | Hypertension | Pitting edema | Other | Lab Findings | Diagnosis method | Gold standard | |
Infectious diseases | Pyelonephritis | + | + | + | + | + | + | - | - |
|
CT and ultrasound: | - | |
Cystitis | - | - | - | + | + | + | - | - |
|
|
|
Urine culture | |
Prostatitis | - | + | - | + | + | + | - | - |
|
|
Ultrasound:
CT scan:
|
- | |
Urethritis | -/- | + | - | + | + | + | - | - |
|
|
CT scan:
|
Urine culture | |
Urogenital trauma | Inserted bladder or ureteral catheters | - | - | - | + | + | + | - | - |
|
Hematuria | Retrograde Urethrography | Retrograde Urethrography |
Lower abdominal mass can be classified to the gynecological and non-gynecological causes. Bladder cancer in the advanced cases can present as a bladder mass. Below table discusses lower abdominal mass causes:
References
- ↑ Donadio JV, Grande JP (2002). "IgA nephropathy". N Engl J Med. 347 (10): 738–48. doi:10.1056/NEJMra020109. PMID 12213946.
- ↑ Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB; et al. (2011). "The pathophysiology of IgA nephropathy". J Am Soc Nephrol. 22 (10): 1795–803. doi:10.1681/ASN.2011050464. PMID 21949093.
- ↑ McCarthy PA, Maino DM (2000). "Alport syndrome: a review". Clin Eye Vis Care. 12 (3–4): 139–150. PMID 11137428.
- ↑ Bodziak KA, Hammond WS, Molitoris BA (1994). "Inherited diseases of the glomerular basement membrane". Am J Kidney Dis. 23 (4): 605–18. PMID 8154501.
- ↑ Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, Boyle MD (July 2004). "Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response". J. Am. Soc. Nephrol. 15 (7): 1785–93. PMID 15213266.
- ↑ Oda T, Yoshizawa N, Yamakami K, Tamura K, Kuroki A, Sugisaki T, Sawanobori E, Higashida K, Ohtomo Y, Hotta O, Kumagai H, Miura S (September 2010). "Localization of nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis". Hum. Pathol. 41 (9): 1276–85. doi:10.1016/j.humpath.2010.02.006. PMID 20708459.
- ↑ Kwoh C, Shannon MB, Miner JH, Shaw A (2006). "Pathogenesis of nonimmune glomerulopathies". Annu Rev Pathol. 1: 349–74. doi:10.1146/annurev.pathol.1.110304.100119. PMID 18039119.
- ↑ Reidy K, Kaskel FJ (March 2007). "Pathophysiology of focal segmental glomerulosclerosis". Pediatr. Nephrol. 22 (3): 350–4. doi:10.1007/s00467-006-0357-2. PMC 1794138. PMID 17216262.
- ↑ D'Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004). "Pathologic classification of focal segmental glomerulosclerosis: a working proposal". Am J Kidney Dis. 43 (2): 368–82. PMID 14750104.
- ↑ Couser WG (1998). "Pathogenesis of glomerular damage in glomerulonephritis". Nephrol Dial Transplant. 13 Suppl 1: 10–5. PMID 9507491.
- ↑ Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY (1996). "Modulators of crescentic glomerulonephritis". J Am Soc Nephrol. 7 (11): 2271–8. PMID 8959617.
- ↑ Jennette JC (March 2003). "Rapidly progressive crescentic glomerulonephritis". Kidney Int. 63 (3): 1164–77. doi:10.1046/j.1523-1755.2003.00843.x. PMID 12631105.
- ↑ Hartman DS, Sanders RC (April 1982). "Wilms' tumor versus neuroblastoma: usefulness of ultrasound in differentiation". J Ultrasound Med. 1 (3): 117–22. PMID 6152936.
- ↑ De Campo JF (1986). "Ultrasound of Wilms' tumor". Pediatr Radiol. 16 (1): 21–4. PMID 3003660.
- ↑ Cahan LD (1985). "Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease". Pediatr Neurosci. 12 (1): 58–62. PMID 4080660.